[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biostem Technologies New (BSEM)

Biostem Technologies New (BSEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 77,245
  • Shares Outstanding, K 16,977
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta 0.09
  • Price/Sales 1.61
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 28.13
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $-0.01 on 03/24/26
  • Next Earnings Date 05/14/26 [AMC]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 2
  • High Estimate $0.04
  • Low Estimate $-0.28
  • Prior Year $0.17
  • Growth Rate Est. (year over year) -170.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.0600 +20.44%
on 05/07/26
5.1500 -5.05%
on 04/14/26
-0.2420 (-4.72%)
since 04/10/26
3-Month
4.0000 +22.25%
on 03/31/26
6.3800 -23.35%
on 02/19/26
-0.6300 (-11.41%)
since 02/12/26
52-Week
3.0932 +58.09%
on 11/17/25
14.8600 -67.09%
on 05/13/25
-10.3050 (-67.82%)
since 05/12/25

Most Recent Stories

More News
BioStem Technologies to Host First Quarter 2026 Financial Results Conference Call on May 14, 2026

POMPANO BEACH, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 4.8100 (+5.71%)
BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer

POMPANO BEACH, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of perinatal...

BSEM : 4.8100 (+5.71%)
BioStem Technologies to Showcase Innovation and Clinical Evidence at Symposium on Advanced Wound Care Spring 2026

POMPANO BEACH, Fla., April 08, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing and commercialization of...

BSEM : 4.8100 (+5.71%)
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

POMPANO BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 4.8100 (+5.71%)
BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025

POMPANO BEACH, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 4.8100 (+5.71%)
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results

POMPANO BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization...

BSEM : 4.8100 (+5.71%)
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair

Pompano Beach, FL, March 23, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for...

BSEM : 4.8100 (+5.71%)
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair

POMPANO BEACH, Fla., March 23, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived...

BSEM : 4.8100 (+5.71%)
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal...

BSEM : 4.8100 (+5.71%)
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference

POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal...

BSEM : 4.8100 (+5.71%)

Business Summary

BioStem Technologies Inc. is a regenerative medicine company. It focused on the development, manufacture and commercialization of placental derived biologics. The company's portfolio of brands includes VENDAJE(R), VENDAJE AC(R) and VENDAJE OPTIC(R). BioStem Technologies Inc. is based in POMPANO BEACH,...

See More

Key Turning Points

3rd Resistance Point 5.1000
2nd Resistance Point 4.8900
1st Resistance Point 4.7200
Last Price 4.8100
1st Support Level 4.3400
2nd Support Level 4.1300
3rd Support Level 3.9600

See More

52-Week High 14.8600
Fibonacci 61.8% 10.3651
Fibonacci 50% 8.9766
Fibonacci 38.2% 7.5881
Last Price 4.8100
52-Week Low 3.0932

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.